We are live on ! Find out more
ALPN

Alpine Immune Sciences Inc

Delisted

ALPN was delisted on the 17th of May, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$32.3M +$260K +40,736 +0.9%
O
2
OrbiMed
New York
$30M
GPP
3
Great Point Partners
Connecticut
$26.7M +$1.21M +189,197 +5%
LCM
4
Lynx1 Capital Management
Puerto Rico
$23M +$446K +69,753 +2%
FLSM
5
Frazier Life Sciences Management
California
$21.9M
PBA
6
Paradigm Biocapital Advisors
New York
$17M +$658K +102,912 +5%
OFM
7
Omega Fund Management
Massachusetts
$14.9M
BlackRock
8
BlackRock
New York
$10.6M +$3.25M +509,137 +55%
Vanguard Group
9
Vanguard Group
Pennsylvania
$10M +$1.52M +237,703 +21%
CC
10
Commodore Capital
New York
$9.74M
OCA
11
Octagon Capital Advisors
New York
$9M
AG
12
Artal Group
Luxembourg
$8.77M
BI
13
BVF Inc
California
$8.35M
APM
14
Avidity Partners Management
Texas
$7.56M +$189K +29,600 +3%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$3.57M +$1.5M +234,246 +93%
Renaissance Technologies
16
Renaissance Technologies
New York
$2.45M -$165K -25,800 -7%
State Street
17
State Street
Massachusetts
$2.23M +$156K +24,436 +9%
TCM
18
TCG Crossover Management
California
$1.86M -$9.59K -1,500 -0.6%
AAA
19
Affinity Asset Advisors
New York
$1.82M +$881K +137,891 +125%
SFM
20
Sphera Funds Management
Israel
$1.47M
Northern Trust
21
Northern Trust
Illinois
$1.41M +$429K +67,094 +54%
CCMU
22
Cheyne Capital Management (UK)
United Kingdom
$1.34M +$1.16M +181,886 New
Bank of New York Mellon
23
Bank of New York Mellon
New York
$614K +$122K +19,111 +30%
Two Sigma Advisers
24
Two Sigma Advisers
New York
$479K -$21.1K -3,300 -5%
Charles Schwab
25
Charles Schwab
California
$474K +$158K +24,673 +62%